title: Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection.
abstract: Airway epithelial cells (AECs) provide the first line of defense in the respiratory tract and are the main target of respiratory viruses. Here, using oligonucleotide and protein arrays, we analyze the infection of primary polarized human AEC cultures with influenza virus and respiratory syncytial virus (RSV), and we show that the immune response of AECs is quantitatively and qualitatively virus specific. Differentially expressed genes (DEGs) specifically induced by influenza virus and not by RSV included those encoding interferon B1 (IFN-B1), type III interferons (interleukin 28A [IL-28A], IL-28B, and IL-29), interleukins (IL-6, IL-1A, IL-1B, IL-23A, IL-17C, and IL-32), and chemokines (CCL2, CCL8, and CXCL5). Lack of type I interferon or STAT1 signaling decreased the expression and secretion of cytokines and chemokines by the airway epithelium. We also observed strong basolateral polarization of the secretion of cytokines and chemokines by human and murine AECs during infection. Importantly, the antiviral response of human AECs to influenza virus or to RSV correlated with the infection signature obtained from peripheral blood mononuclear cells (PBMCs) isolated from patients with acute influenza or RSV bronchiolitis, respectively. IFI27 (also known as ISG12) was identified as a biomarker of respiratory virus infection in both AECs and PBMCs. In addition, the extent of the transcriptional perturbation in PBMCs correlated with the clinical disease severity. Our results demonstrate that the human airway epithelium mounts virus-specific immune responses that are likely to determine the subsequent systemic immune responses and suggest that the absence of epithelial immune mediators after RSV infection may contribute to explaining the inadequacy of systemic immunity to the virus.
authors.affiliation: Center for Vaccines and Immunity, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
authors.forename: Ioannis
authors.initials: I
authors.lastname: Ioannidis
authors.forename: Beth
authors.initials: B
authors.lastname: McNally
authors.forename: Meredith
authors.initials: M
authors.lastname: Willette
authors.forename: Mark E
authors.initials: ME
authors.lastname: Peeples
authors.forename: Damien
authors.initials: D
authors.lastname: Chaussabel
authors.forename: Joan E
authors.initials: JE
authors.lastname: Durbin
authors.forename: Octavio
authors.initials: O
authors.lastname: Ramilo
authors.forename: Asuncion
authors.initials: A
authors.lastname: Mejias
authors.forename: Emilio
authors.initials: E
authors.lastname: Flaño
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D016207:Cytokines / Q000276:immunology; D004847:Epithelial Cells / Q000276:immunology* / Q000821:virology; D005260:Female; D006801:Humans; D007223:Infant; D009980:Influenza A virus / Q000276:immunology* / Q000502:physiology; D007251:Influenza, Human / Q000276:immunology / Q000821:virology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D018345:Mice, Knockout; D018357:Respiratory Syncytial Virus Infections / Q000276:immunology / Q000821:virology*; D012136:Respiratory Syncytial Viruses / Q000276:immunology* / Q000502:physiology; D012141:Respiratory Tract Infections / Q000276:immunology / Q000821:virology*; D013045:Species Specificity
chemical_list: D016207:Cytokines